Author:
Muñoz-Villaverde Sergio,Martínez-García María,Serrano-Oviedo Leticia,Gómez-Romero Francisco Javier,Sobrado-Sobrado Ana María,Cidoncha-Moreno María Ángeles,Riesgo-Martín Juan,Pedreira-Robles Guillermo,Garcimartin Paloma
Abstract
Abstract
Background
During the COVID-19 pandemic, decentralised clinical trials incorporated self-monitoring, self-reporting, and telenursing tools to address health literacy and health empowerment of patients enrolled in clinical trials. We aimed to determine the impact of an educational intervention using telenursing consultations on health literacy, health empowerment, and health-related quality of life in cancer patients enrolled in clinical trials by measuring the level of satisfaction with the care received and assessing the views of healthcare professionals concerning the advanced practice nurse (APN) role in oncology clinical trials.
Methods
In this pilot analytical, descriptive, longitudinal, quasi-experimental, and pre-post test study, an educational intervention was conducted by 5 visits with an APN using synchronous teleconsultation in patients starting cancer treatment for the first time in a clinical trial (n = 60), and health professionals working with the APN (n = 31). A descriptive analysis of the samples and questionnaires were utilised along with statistical comparisons.
Results
After the intervention, patients' health literacy (31.7%), health empowerment (18.3%), and health-related quality of life (33.3%) increased (p < 0.05), with a decrease and trend towards resolution of care needs (p < 0.05). Satisfaction with the quality and care received in terms of perceived convenience, transition, and continuity of care showed positive results in 64.9 ± 20.7, 77.6 ± 19.5, and 72.1 ± 20.4 of respondents, respectively. On the overall assessment of the APN role, healthcare professionals expressed a high level of agreement with the statements related to their work performance.
Conclusions
The data indicates that a clinical trial APN-led telenursing educational intervention results in an overall increase in health literacy, an improvement in health empowerment and health-related quality of life, and a decrease in care needs of oncology clinical trials patients. Patients stated that they received a high quality of care and health professionals indicated high levels of acceptance with APNs. Based on these results, we suggest that the APN role should gain more recognition in the Spanish healthcare system and their professional competencies should be aligned with those of other countries.
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Martín Uranga, A. Investigación Clínica en Centros Privados datos del proyecto BEST. 2014. .https://www.farmaindustria.es/web/wp-content/uploads/sites/2/2014/03/14-03-16 Presentaci%C3%B3n-jornada-26-marzo.pdf. Accessed Jun 2023.
2. Guerrero-Molina A, Millán-Vázquez G, Cruzado-Álvarez C. The clinical trials nurse in the hospital setting: an unknown figure. Cardiocore. 2018;48(2):75–8. https://doi.org/10.1016/j.carcor.2012.10.010.
3. Welch MA, Ryan JC, Galinsky IA. Role of the advanced practice provider in clinicaltrials: contributions to the management of patients receiving inotuzumab ozogamicin. J Adv Pract Oncol. 2017;8(6):631–6.
4. Flocke SA, Antognoli E, Daly BJ, Jackson B, Fulton SE, Liu TM, et al. The role of oncology nurses in discussing clinical trials. Oncol Nurs Forum. 2017;44(5):547–53. https://doi.org/10.1188/17.ONF.547-552.
5. Sadler GR, Lantz JM, Fullerton JT, Dault Y. Nurses’ unique roles in randomized clinical trials. J Prof Nurs. 1999;15(2):106–15. https://doi.org/10.1016/s8755-7223(99)80081-7.